Page last updated: 2024-09-04

maltohexaose and Epilepsy Progressive Myoclonic 2

maltohexaose has been researched along with Epilepsy Progressive Myoclonic 2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Auger, KD; Brewer, MK; Bridges, TM; Chakravarthy, S; Dukhande, VV; Gentry, MS; Hellman, LM; Hsu, S; Husodo, S; Li, S; Meekins, DA; Paasch, BC; Parker, MW; Raththagala, M; Sanz, P; Sherwood, AR; Taylor, AO; Turner, BD; Vander Kooi, CW; Wong, BK; Woods, VL	1

Other Studies

1 other study(ies) available for maltohexaose and Epilepsy Progressive Myoclonic 2

Article	Year
Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease. Molecular cell, 2015, Jan-22, Volume: 57, Issue:2 Topics: Catalytic Domain; Crystallography, X-Ray; Glycogen; Humans; Lafora Disease; Models, Molecular; Oligosaccharides; Phosphates; Phosphorylation; Protein Binding; Protein Multimerization; Protein Structure, Secondary; Protein Tyrosine Phosphatases, Non-Receptor	2015

Article

Year

Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease.

Molecular cell, 2015, Jan-22, Volume: 57, Issue:2

Topics: Catalytic Domain; Crystallography, X-Ray; Glycogen; Humans; Lafora Disease; Models, Molecular; Oligosaccharides; Phosphates; Phosphorylation; Protein Binding; Protein Multimerization; Protein Structure, Secondary; Protein Tyrosine Phosphatases, Non-Receptor

2015